Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion type Assertion NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_head.
- NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion wasGeneratedBy ECO_0000203 NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_provenance.
- NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion wasDerivedFrom befree-20140225 NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_provenance.
- NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion SIO_000772 17079443 NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_provenance.
- NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion evidence source_evidence_literature NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_provenance.
- NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_assertion description "[Loss of G(1)-S control and aberrations of the p16(Ink4a)-cyclin D1/cyclin-dependent kinase (CDK) 4(6)-pRb-E2F-cyclin E/CDK2 pathway are common in human cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341267.RAolV3Mi9INYDR-qZuNLvvqNuAMxX8ZJ18uihQaSqZeIs130_provenance.